Primary corneal amyloidosis occupies a specific, important place in the differential diagnosis of corneal clouding: amyloid deposition confined to the cornea, without an identifiable systemic amyloid disease and without fitting the pattern of a defined hereditary corneal dystrophy like lattice dystrophy, and correctly placing a given patient’s findings into this category, rather than one of the other amyloid-related possibilities, shapes both the workup pursued and the counseling offered.

Clinical eye photograph illustrating Corneal Amyloidosis Primary

Amyloid in the Cornea: Several Different Stories

Amyloid deposition in the cornea is not a single diagnosis but rather a shared histologic finding that can arise through several distinct mechanisms, and distinguishing between them is the central diagnostic task whenever corneal amyloid is identified or suspected.

  • Lattice corneal dystrophy, a specific, well-characterized hereditary condition producing the classic branching refractile lines, resulting from TGFBI gene mutations (see lattice corneal dystrophy)
  • Gelatinous drop-like corneal dystrophy, a distinct hereditary condition producing dramatic, elevated, mulberry-shaped masses from a different genetic cause (see gelatinous drop-like corneal dystrophy)
  • Secondary corneal amyloidosis, developing within a cornea chronically affected by another condition, including longstanding trachoma, chronic keratoconjunctivitis, or other prolonged ocular surface inflammatory or degenerative disease, where amyloid accumulates as a late, localized consequence of the underlying chronic process
  • Primary (localized) corneal amyloidosis, in which amyloid deposition occurs within the cornea without an identifiable hereditary corneal dystrophy syndrome and without evidence of systemic amyloid disease, representing a more idiopathic, localized process

Clinical Presentation

  • Gradual, progressive corneal clouding or the development of visible deposits, without the specific, recognizable pattern of lattice lines or gelatinous mulberry masses that would point to one of the named hereditary dystrophies
  • Reduced vision correlating with the extent and density of the amyloid deposition
  • Typically lacks the early, severe recurrent erosion prominent in some of the hereditary Bowman-layer and stromal dystrophies, though surface irregularity and mild erosion symptoms can still occur
  • A relevant history of chronic ocular surface disease or prior significant ocular inflammation supports a secondary rather than primary process

Test your knowledge 10 questions from this article
Choroida · Slit-lamp imaging

All-fit Slit-Lamp Adapter

Record and share exactly what you see at the slit lamp. One adapter fits any slit lamp or surgical microscope — and any smartphone.

From Choroida — the team behind this site

Diagnostic Evaluation

  • Careful slit-lamp examination to assess whether the deposition pattern matches a recognized hereditary dystrophy syndrome, since a pattern-matched diagnosis (lattice or gelatinous drop-like dystrophy) is generally more specific and informative than a default label of primary amyloidosis
  • A thorough history for any chronic ocular surface disease, prior trachoma exposure, or longstanding keratoconjunctivitis that could explain a secondary process
  • A family history, since hereditary corneal dystrophies are typically inherited in recognizable patterns, while primary localized amyloidosis without an underlying dystrophy syndrome is generally sporadic
  • Biopsy or examination of surgically excised tissue with Congo red staining confirms the presence of amyloid and supports histologic characterization, though it does not on its own distinguish between the various possible underlying causes without correlation with the clinical picture and genetic testing when appropriate
  • Systemic evaluation for amyloidosis is generally reserved for cases with other suggestive systemic findings, since isolated corneal amyloid deposition without a hereditary dystrophy pattern is usually a localized phenomenon rather than a marker of systemic disease

Management

Addressing Any Underlying Cause

When corneal amyloidosis is secondary to chronic ocular surface disease, managing that underlying condition is an important part of care, both for its own sake and to reduce ongoing stimulus for further amyloid accumulation.

Surgical Management of Visually Significant Deposits

  • Phototherapeutic keratectomy can address more superficial amyloid deposits, improving corneal surface regularity and clarity
  • Corneal transplantation, lamellar or penetrating depending on the depth and extent of involvement, is used for deeper, more visually significant deposition not adequately addressed by phototherapeutic keratectomy

Monitoring for Recurrence

As with the hereditary amyloid-related corneal dystrophies, localized recurrence of amyloid deposition after surgical treatment is possible, particularly when an underlying chronic secondary cause remains active, supporting ongoing follow-up after any surgical intervention.


Confirming the diagnosis

Amyloid shows apple-green birefringence under polarized light after Congo red staining, which helps in the pathologic diagnosis of removed tissue. Genetic testing is available for the common TGFBI-related and gelsolin-related forms. In a patient with lattice lines, ask about systemic features, particularly facial palsy and skin laxity in gelsolin amyloidosis, because these influence referral.


Prognosis

Prognosis depends substantially on correctly identifying which category of corneal amyloid deposition a given patient has, since secondary amyloidosis tied to an actively ongoing chronic surface disease may continue to progress or recur unless that underlying driver is controlled, while isolated, treated deposits without an ongoing stimulus often have a more stable long-term course.

Careful diagnostic categorization at the outset, distinguishing primary localized disease from a hereditary dystrophy syndrome or a secondary process with its own specific driver, supports the most accurate counseling and the most appropriately targeted management plan for each individual patient.


All-fit smartphone adapter on a slit lampFundus Explorer Pro smartphone fundus camera
Choroida · Clinical imaging

Document what you see

Two smartphone imaging tools built for everyday clinic use — one for the slit lamp, one for the fundus.

From Choroida — the team behind this site

References

  1. Rodrigues MM, Gaster RN, Pratt MV. Unusual immunoglobulin deposits in lattice corneal dystrophy. Invest Ophthalmol Vis Sci. 1981;20:124-132.
  2. Meisler DM, Fine M. Recurrence of the clinical signs of lattice corneal dystrophy (type I) in corneal transplants. Am J Ophthalmol. 1984;97:210-214.
  3. Klintworth GK. Corneal dystrophies. Orphanet J Rare Dis. 2009;4:7.
  4. Rummelt V, Meyer HJ, Naumann GO. Secondary corneal amyloidosis in interstitial keratitis of congenital lues. Br J Ophthalmol. 1992;76:246-248.

Test yourself

A few questions straight from this article.

1 / 10 0 correct
  1. Primary corneal amyloidosis is defined by amyloid deposition with which feature?